Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence

Fernando Mora, Carlos Gómez Sánchez-Lafuente, Mariano De Iceta, Carolina Roset, Antonio Cárdenas, Daniel Pérez, Elena Álvarez-Barón, Irene Gabarda-Inat, Savana Research Group · 2025

Read Lurasidone uses and dosages in Spain: RETROLUR, a real-world retrospective analysis using artificial intelligence by Fernando Mora, Carlos Gómez Sánchez-Lafuente, Mariano De Iceta, Carolina Roset, Antonio Cárdenas, Daniel Pérez, Elena Álvarez-Barón, Irene Gabarda-Inat, Savana Research Group (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11862477.txt.

Description

Mora and colleagues mined hospital records in twenty twenty-four to see how the antipsychotic drug lurasidone is really used in Spain. The drug treats schizophrenia and bipolar depression, but published data on everyday practice were scarce.

Using language-processing software, the team read the records of four hospitals and found two hundred seventy-two people who started the drug between twenty nineteen and twenty twenty-two. Most had tried a median of three earlier antipsychotics. Doses in practice stayed low, and under one percent of patients reached the highest doses. About seventeen percent stopped the drug during follow-up. Symptoms of psychosis, anxiety, and depression all grew less frequent after starting, and reported side effects fell compared with the period before. The authors say real-world use looks gentler than trial use. Low dosing, they note, may leave some benefit untapped.

Catalog record

CREATORFernando Mora, Carlos Gómez Sánchez-Lafuente, Mariano De Iceta, Carolina Roset, Antonio Cárdenas, Daniel Pérez, Elena Álvarez-Barón, Irene Gabarda-Inat, Savana Research Group
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11862477

Browse the full library · About the Tower of Babel